OSAKA, Japan, July 23, 2024 /PRNewswire/ -- Linical, a global
Contract Research Organization (CRO) for full-service drug
development, has been awarded the title of Best Global CRO
2024 by Global Health & Pharma (GHP) Magazine. The
award comes as part of the publication's annual Global Excellence
Awards.
The 2024 Global Excellence Awards, now in their fifth year,
have been designed to recognize the remarkable contributions made
by professionals, organizations, and initiatives that are shaping
the future of the wider healthcare, pharmaceutical, and life
sciences industries. Winners of the award are considered leading
players in their field, who set the highest standards of excellence
and provide innovative medical solutions. Award winners are
selected by the GHP Magazine committee, based on thorough analysis
and an objective research process to award titles based purely on
merit. The Global Excellence Awards celebrate those who have pushed
the boundaries of possibility, redefined industry standards, and
made significant strides in addressing the pressing challenges that
impact the global landscape.
"On behalf of Linical, we are honored to be named the Best
Global CRO" stated Clareece
West, President and CCO, America and Europe. "It is remarkable to see what we have
achieved as we enter our 20th year of business. We have
been very thoughtful as we have grown, maintaining our commitment
to providing flexible clinical development solutions for pharma and
biotech clients of all sizes. Much of our business is through
referrals from clients, which is a testament to our reputation for
providing high quality services and successful clinical studies. We
are proud to offer comprehensive coverage across the Americas,
Europe, and APAC with our own
dedicated staff. Our team is committed to quality and innovative
thinking, with a shared goal of advancing promising, life-changing
therapies for patients across the globe. Here at Linical, we
believe we have the right size, right reach, and right team to
support our clients throughout their entire clinical development
journey."
About Linical
Linical is a public, mid-sized Contract Research Organization
headquartered in Japan with a
significant presence across all major markets including
North America, Europe, and Asia-Pacific. Linical provides the full
spectrum of drug development services from early stage to
large-scale, multinational studies. Our areas of focus include
Phase I-IV studies in oncology, neurology & psychiatry,
immunology & vaccine, and endocrinology & metabolic
diseases.
Logo -
https://mma.prnewswire.com/media/2463993/Brand_Logo_All_Color_Logo_Logo.jpg
Photo -
https://mma.prnewswire.com/media/2463994/Jun24281_Linical_GHP_Mags_2024__Winners_Badge.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/linical-named-best-global-cro-by-global-health--pharma-magazine-302199905.html